China · Delayed Price · Currency is CNY Porton Pharma Solutions Statistics
Total Valuation
SHE:300363 has a market cap or net worth of CNY 11.76 billion. The enterprise value is 12.01 billion.
| Market Cap | 11.76B |
| Enterprise Value | 12.01B |
Important Dates
The last earnings date was Saturday, April 4, 2026.
| Earnings Date | Apr 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300363 has 540.16 million shares outstanding. The number of shares has decreased by -1.42% in one year.
| Current Share Class | 540.16M |
| Shares Outstanding | 540.16M |
| Shares Change (YoY) | -1.42% |
| Shares Change (QoQ) | +5.17% |
| Owned by Insiders (%) | 26.98% |
| Owned by Institutions (%) | 8.74% |
| Float | 311.45M |
Valuation Ratios
The trailing PE ratio is 120.94 and the forward PE ratio is 58.84.
| PE Ratio | 120.94 |
| Forward PE | 58.84 |
| PS Ratio | 3.44 |
| PB Ratio | 2.14 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | 25.32 |
| P/OCF Ratio | 15.53 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.43, with an EV/FCF ratio of 25.85.
| EV / Earnings | 124.63 |
| EV / Sales | 3.51 |
| EV / EBITDA | 20.43 |
| EV / EBIT | 56.89 |
| EV / FCF | 25.85 |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.27.
| Current Ratio | 1.82 |
| Quick Ratio | 1.25 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 2.57 |
| Debt / FCF | 3.25 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.56% and return on invested capital (ROIC) is 1.35%.
| Return on Equity (ROE) | 0.56% |
| Return on Assets (ROA) | 1.52% |
| Return on Invested Capital (ROIC) | 1.35% |
| Return on Capital Employed (ROCE) | 3.12% |
| Weighted Average Cost of Capital (WACC) | 7.17% |
| Revenue Per Employee | 811,540 |
| Profits Per Employee | 22,862 |
| Employee Count | 4,200 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 3.11 |
Taxes
In the past 12 months, SHE:300363 has paid 52.29 million in taxes.
| Income Tax | 52.29M |
| Effective Tax Rate | 63.25% |
Stock Price Statistics
The stock price has increased by +14.38% in the last 52 weeks. The beta is 0.70, so SHE:300363's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +14.38% |
| 50-Day Moving Average | 22.64 |
| 200-Day Moving Average | 23.01 |
| Relative Strength Index (RSI) | 51.08 |
| Average Volume (20 Days) | 10,190,858 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300363 had revenue of CNY 3.42 billion and earned 96.34 million in profits. Earnings per share was 0.18.
| Revenue | 3.42B |
| Gross Profit | 1.02B |
| Operating Income | 211.03M |
| Pretax Income | 82.68M |
| Net Income | 96.34M |
| EBITDA | 570.05M |
| EBIT | 211.03M |
| Earnings Per Share (EPS) | 0.18 |
Balance Sheet
The company has 1.41 billion in cash and 1.51 billion in debt, with a net cash position of -99.74 million or -0.18 per share.
| Cash & Cash Equivalents | 1.41B |
| Total Debt | 1.51B |
| Net Cash | -99.74M |
| Net Cash Per Share | -0.18 |
| Equity (Book Value) | 5.50B |
| Book Value Per Share | 9.86 |
| Working Capital | 1.48B |
Cash Flow
In the last 12 months, operating cash flow was 757.01 million and capital expenditures -292.57 million, giving a free cash flow of 464.45 million.
| Operating Cash Flow | 757.01M |
| Capital Expenditures | -292.57M |
| Depreciation & Amortization | 359.02M |
| Net Borrowing | -383.60M |
| Free Cash Flow | 464.45M |
| FCF Per Share | 0.86 |
Margins
Gross margin is 29.94%, with operating and profit margins of 6.17% and 2.82%.
| Gross Margin | 29.94% |
| Operating Margin | 6.17% |
| Pretax Margin | 2.42% |
| Profit Margin | 2.82% |
| EBITDA Margin | 16.67% |
| EBIT Margin | 6.17% |
| FCF Margin | 13.58% |
Dividends & Yields
SHE:300363 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 31.25% |
| Buyback Yield | 1.42% |
| Shareholder Yield | 1.42% |
| Earnings Yield | 0.82% |
| FCF Yield | 3.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 29, 2015. It was a forward split with a ratio of 1.5.
| Last Split Date | Sep 29, 2015 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |